Trusting the science that drives your business: A systematic approach to verify scientific claims
Updated 30 Apr 2013
The time has come for an independent, systematic and unbiased process for auditing scientific claims to help increase consumer confidence in scientific outcomes, reduce risks and generate more value.
Learn more and read the executive report
Fade or flourish? Rethinking the role of life sciences companies in the healthcare ecosystem
Updated 22 Aug 2011
Facing business model challenges and dramatic changes in the healthcare ecosystem, today’s life sciences must rethink how they engage with the other stakeholders in the healthcare ecosystem.
The future of connected health devices: Liberating the Information Seeker
Updated 30 Mar 2011
Health device makers have a chance to capture a large, emerging market if they approach this opportunity with comprehensive, integrated solutions.
The wisdom of the cloud: Cloud computing in the life sciences industry
Updated 12 Nov 2010
Cloud computing in life sciences can facilitate innovation and help create new, more efficient business models.
Collaborative innovation: Partnering for success in Life Sciences
Updated 25 Oct 2010
The ability to tap new sources of innovation is becoming more important than ever, as declining R&D productivity, the "patent cliff" and intense generic competition all take their toll on Big Pharma.
Growth and collaboration: Embracing new challenges facing China's life sciences market
Updated 22 Apr 2010
China's essential drug list will create challenges and opportunities for China’s pharmaceutical companies, distributors and hospitals, and will trigger changes in how they operate.
Prescription for healthier growth: Shaping China's life sciences market
Updated 23 Jul 2009
Competitors in China’s life sciences market should prepare themselves for the market’s massive changes and continued growth by increasing their capabilities in three key areas: innovation; manufacturing quality; and sales, marketing and distribution.
The new biopharmaceutical blueprint: Aligning business and IT with service-oriented architecture
Updated 21 Apr 2009
Service-oriented architecture (SOA) can serve as the new blueprint for aligning business and IT.
Cultivating innovation beyond corporate walls: Alliances between the life sciences industry and academia
Updated 09 Feb 2009
Within an industry in need of the type of collaboration that gave rise to the biotech era, new models are emerging that can facilitate partnership between life sciences companies and academic institutions, diminish the sting of past failures and result in significant therapeutic advances.
A marriage of minds: Making biopharmaceutical collaborations work
Updated 19 Jan 2009
Fewer than half the respondents in the latest biopartnering survey jointly conducted by the IBM Institute for Business Value and Silico Research say that their alliances have met their expectations
Advancing the utility of imaging biomarkers: Insights from the second Imaging Biomarker Summit
Updated 19 Jan 2009
Imaging biomarkers hold great promise to assuage some of society’s costliest challenges, and technology can accelerate progress as the full ecosystem - including government, academia, BioPharma industry and imaging industry - contributes toward achieving this vision.
The evolving role of biomarkers: Focusing on patients from research to clinical practice
Updated 19 Jan 2009
The science of biomarker-enabled R&D is advancing quicker than general acceptance. To realize the full potential of biomarkers, the industry must take actions to increase the confidence of regulators, the medical community and the public at large.
Imperfect harmony: Alliances within the life sciences industry
Updated 09 Dec 2008
Partnerships are vital to large biopharmaceutical companies - and yet many lack the collaborative capabilities they need. This study outlines the characteristics biotechs and academics are looking for in a partner and suggests ways larger companies can become more attractive suitors.
The Enterprise of the Future: IBM Global CEO Study - Life Sciences Edition
Updated 11 Aug 2008
CEOs across the Life Sciences industry weigh in on the future of business.
In the interest of the patient: Convergence across the pharmaceutical and healthcare industries
Updated 12 Dec 2006
To make serious strides toward improving patient health, the pharmaceutical and healthcare industries need to marshall their collective data assets and collaborate more closely.
The eClinical equation: Part 2 – Bridging connections for innovation
Updated 25 Oct 2006
The pharmaceutical industry (Pharma) is at a critical point in its transition to a new model of drug development: making targeted medicines.
Pharma's new world view: Transforming R&D through emerging markets
Updated 30 Sep 2006
Pharma's new world view: Transforming R&D through emerging markets
Learning the biopartnering game: How to achieve more from your biotech alliance
Updated 14 Feb 2006
Recent advances in molecular science are expected to yield medical treatments targeted not just for individual ailments, but also for highly segmented patient groups. As they pursue this exciting vision, pharmaceutical and biotechnology (biotech) companies are actively engaging in alliances.
Contact us
IBM Industries
-
IdeaWatch Newsletter
Sign up to receive monthly e-mail updates on recent papers from the IBM Institute for Business Value.